Binding of α-synuclein to ACO2 promotes progressive mitochondrial dysfunction in Parkinson's disease models
Open Access
- 17 October 2024
- journal article
- research article
- Published by Elsevier in Redox Biology
- Vol. 77, 103399
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
This publication has 50 references indexed in Scilit:
- Serine-129 phosphorylation of α-synuclein is an activity-dependent trigger for physiologic protein-protein interactions and synaptic functionNeuron, 2023
- Protein posttranslational modifications in health and diseases: Functions, regulatory mechanisms, and therapeutic implicationsMedcomm, 2023
- Redox sensitive human mitochondrial aconitase and its interaction with frataxin: In vitro and in silico studies confirm that it takes two to tangoFree Radical Biology and Medicine, 2023
- Common Mechanisms Underlying α-Synuclein-Induced Mitochondrial Dysfunction in Parkinson’s DiseaseJournal of Molecular Biology, 2023
- Fatal attraction – The role of hypoxia when alpha-synuclein gets intimate with mitochondriaNeurobiology of Aging, 2021
- α-Synuclein emerges as a potent regulator of VDAC-facilitated calcium transportCell Calcium, 2021
- α-Synuclein aggregation and transmission in Parkinson’s disease: a link to mitochondria and lysosomeScience China Life Sciences, 2020
- Infantile Cerebellar-Retinal Degeneration Associated with a Mutation in Mitochondrial Aconitase, ACO2The American Journal of Human Genetics, 2012
- Iron toxicity in neurodegenerationBioMetals, 2012
- A Note on a Simple Apparatus for Detecting Neurological Deficit in Rats and Mice**College of Pharmacy, University of Nebraska, Lincoln 8.Journal of the American Pharmaceutical Association (Scientific ed.), 1957